NOVALGIN

This brand name is authorized in Austria, Germany, Turkey

Active ingredients

The drug NOVALGIN contains one active pharmaceutical ingredient (API):

1 Metamizole sodium UNII VSU62Z74ON - METAMIZOLE SODIUM

Metamizole sodium is a pyrazolone derivative with analgesic, antipyretic and slight antiinflammatory and spasmolytic properties. It has the most potent analgesic effect of all the pyrazolone derivatives. As with other analgesics, its mechanism of action has not been elucidated in detail. It includes inhibition of prostaglandin synthesis (PGE1 and PGE2) and reversible inhibition of platelet aggregation. It inhibits cyclo-oxygenase and influences the effect of arachidonic acid. Read about Metamizole sodium

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NOVALGIN Solution for injection	Web Search	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02BB02	Metamizole sodium	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BB Pyrazolones
Discover more medicines within N02BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00237848, 00731465, 00731531, 00731577, 00731583, 00731672, 01553758, 01599654, 03059407, 04527098, 06053291
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683060570052, 8683060590012, 8683060750102, 8683060750126, 8699809015012, 8699809018549